Skip to main content
. 2022 Jun 23;9:842856. doi: 10.3389/fnut.2022.842856

Table 1.

Baseline characteristics of all included participants.

Variables Total (n = 626) Survival group (n = 304) Non-CVD death group (n = 223) CVD death group (n = 99) P
Gender, n (%) 0.312
Male 358 (53.07) 157 (49.95) 134 (57.02) 67 (56.75)
Female 268 (46.93) 147 (50.05) 89 (42.98) 32 (43.25)
Age, year, Mean (S.E) 66.85 (0.81) 62.18 (0.94) 72.24 (1.03) 73.59 (1.48) <0.001
BMI, kg/m2, Mean (S.E) 29.73 (0.31) 30.22 (0.47) 28.93 (0.39) 29.57 (1.03) 0.101
Race, n (%) 0.340
Mexican American 78 (3.07) 43 (3.60) 25 (2.44) 10 (2.31)
Other Hispanic 6 (0.74) 4 (0.82) 1 (0.47) 1 (1.07)
Non-Hispanic White 426 (83.64) 179 (80.91) 171 (86.42) 76 (88.43)
Non-Hispanic Black 96 (8.43) 69 (11.08) 18 (5.26) 9 (4.92)
Other Race 20 (4.12) 9 (3.60) 8 (5.42) 3 (3.26)
Education, n (%) 0.072
At least high school 415 (74.57) 209 (78.64) 140 (68.91) 66 (70.89)
Less than high school 210 (25.43) 95 (21.36) 82 (31.09) 33 (29.11)
Family income to poverty ratio (PIR), Mean (S.E) 2.72 (0.08) 2.87 (0.12) 2.46 (0.11) 2.69 (0.17) 0.040
Smoking status, n (%) 0.794
Yes 330 (53.54) 166 (54.74) 113 (52.59) 51 (50.80)
No 296 (46.46) 138 (45.26) 110 (47.41) 48 (49.20)
Alcohol, gm, Mean (S.E) 6.89 (1.03) 7.49 (1.58) 5.68 (1.36) 7.21 (2.10) 0.634
Protein, gm, Mean (S.E) 71.83 (1.86) 73.70 (2.53) 71.42 (3.31) 65.10 (3.29) 0.123
Cholesterol, n (%) 0.111
Yes 580 (93.31) 277 (91.71) 207 (94.25) 96 (97.67)
No 46 (6.69) 27 (8.29) 16 (5.75) 3 (2.33)
Total fat, gm, Mean (S.E) 72.53 (2.05) 75.17 (3.27) 71.60 (3.78) 63.88 (4.25) 0.072
Carbohydrate, gm, Mean (S.E) 227.91 (6.03) 236.20 (7.52) 224.39 (9.21) 202.02 (9.36) 0.008
eGFR, mL/min/m2, Mean (S.E) 68.34 (0.94) 74.85 (1.34) 60.35 (1.87) 60.08 (2.64) <0.001
Energy, 10 kcal, Mean (S.E) 183.93 (4.01) 188.62 (5.55) 182.28 (6.22) 168.53 (6.85) 0.015
Hypertension, n (%) 0.340
Yes 446 (70.69) 217 (68.40) 68 (73.48) 161 (73.78)
No 180 (29.31) 87 (31.60) 31 (26.52) 61 (26.22)
The history of CVD medications, n (%) <0.001
Yes 525 (82.07) 235 (75.30) 201 (89.79) 89 (92.05)
No 101 (17.93) 69 (24.70) 22 (10.21) 10 (7.95)
Diabetes 0.223
Yes 11 (1.59) 7 (2.12) 2 (0.81) 2 (1.20)
No 174 (31.81) 99 (35.72) 48 (26.29) 27 (28.50)
Unknown 441 (66.60) 198 (62.16) 173 (72.90) 70 (70.30)
Cancer, n (%) <0.001
Yes 114 (19.07) 41 (13.91) 51 (26.67) 22 (22.71)
No 512 (80.93) 263 (86.09) 172 (73.33) 77 (77.29)
Coffee, n (%) 0.191
<1 cup per day 137 (21.80) 75 (25.48) 43 (17.66) 19 (16.23)
1–3 cups per day 412 (64.04) 192 (60.51) 153 (68.98) 67 (67.12)
≥4 cups per day 77 (14.16) 37 (14.01) 27 (13.36) 13 (16.66)
Caffeine, 100 mg, Mean (S.E) 2.05 (0.11) 2.03 (0.18) 2.14 (0.19) 1.91 (0.22) 0.794
Iced tea, n (%) 0.773
<1 cup per day 531 (84.43) 264 (86.23) 183 (81.14) 84 (84.65)
1–3 cups per day 78 (11.47) 34 (9.89) 31 (14.38) 13 (11.26)
≥4 cups per day 17 (4.09) 6 (3.88) 9 (4.48) 2 (4.09)
Hot tea, n (%) 0.773
<1 cup per day 570 (90.71) 279 (90.28) 207 (92.81) 84 (87.68)
1–3 cups per day 49 (7.54) 21 (7.62) 13 (5.33) 15 (12.32)
≥4 cups per day 7 (1.74) 4 (2.10) 3 (1.86) 0 (0.00)
Decaffeinated coffee, n (%) 0.547
Almost never 335 (55.33) 153 (52.85) 127 (59.32) 55 (56.30)
About a quarter to three quarters of the time 101 (16.16) 58 (18.31) 30 (14.03) 13 (12.28)
Always 190 (28.51) 93 (28.84) 66 (26.65) 31 (31.42)
Decaffeinated iced tea, n (%) <0.001
Almost never 447 (71.75) 199 (65.04) 177 (82.95) 71 (73.50)
About a quarter to three quarters of the time 103 (16.63) 68 (22.14) 24 (9.40) 11 (10.69)
Always 76 (11.62) 37 (12.82) 22 (7.65) 17 (15.81)
Decaffeinated hot tea, n (%) <0.001
Almost never 447 (72.22) 204 (67.73) 178 (82.49) 65 (66.93)
About a quarter to three quarters of the time 85 (13.75) 56 (17.75) 17 (6.97) 12 (12.97)
Always 94 (14.04) 44 (14.53) 28 (10.54) 22 (20.10)
Follow-up time, months, Mean (S.E) 104.07 (2.56) 131.71 (2.01) 70.70 (2.64) 67.64 (5.06) <0.001

BMI, body mass index; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate.